OraVax, Inc.
38 Sidney Street
Cambridge
Massachusetts
02139
United States
Tel: 617-494-1339
Fax: 617-494-1741
Website: http://www.oravax.com/
2 articles about OraVax, Inc.
-
Premas Biotech and Oravax Medical to Test Their Triple Antigen Oral Vaccine Candidate Against Omicron Variant of Concern
12/1/2021
Premas Biotech announced today that its joint venture Oravax will initiate testing of their oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus through preclinical, in vitro and challenge studies to assess its efficacy for the new mutant strain.
-
Oramed Pharmaceuticals said that its majority-owned firm Oravax Medical would be spearheading the project, first in Israel and later in other international clinical locations.